Because MET has not achieved improvements of ventilatory function in T2D patients with OSA, it was suggested that DAPA played major role in this finding [106, 107]
They do not replace resistance training, protein intake, nutrition control, or metabolic care
Titration is key: Gradual dose escalation maximizes tolerability
GLP-1 Drugs: Benefits Regulate Blood Sugar Levels Curb Appetite and Cravings Facilitate Weight Loss GLP-1 Drugs: Challenges Side Effects: Nausea, Vomiting, Diarrhea, Constipation Muscle Loss Supply Issues and Cost Difficult to Maintain Long-Term Not a Long-Term Solution While GLP-1 drugs may offer initial weight loss, potential drawbacks can include unpleasant side-effects, muscle-loss, and weight regain upon cessation
February 2024: The United States Judicial Panel on Multidistrict Litigation approved the creation of a federal MDL to consolidate the gastrointestinal claims against Ozempic and other GLP-1 drugs
Frmond B., Jouan H., Sameh A